期刊文献+

骨桥蛋白与TIP30基因在口腔鳞癌中的表达 被引量:1

Expression of osteopontin and TIP30 genes in oral squamous cell carcinoma
下载PDF
导出
摘要 目的:研究口腔鳞状细胞癌(OSCC)中骨桥蛋白(osteopontin,OPN)和TIP30基因的表达及意义。方法:用实时荧光定量PCR法检测OSCC(n=18)组织和癌旁正常口腔黏膜(n=18)OPN及TIP30 mRNA的表达;用免疫组织化学En VisionTM法检测OSCC组织石蜡切片(n=70)和正常口腔黏膜(n=20)中OPN和TIP30蛋白的表达。用SPSS 17.0软件进行统计分析。结果:OPN在OSCC组织中的mRNA和蛋白表达水平高于正常组织(P<0.01);TIP30基因在正常组织中mRNA和蛋白表达水平高于OSCC组织(P<0.01)。OPN、TIP30基因的表达呈负相关性(P<0.05)。结论:OPN可能参与了OSCC的发生发展;TIP30基因对OSCC的作用可能与OPN相反。 Objective: To study the expressions of osteopontin (OPN) and TIP30 genes in oral squamous cell carcinoma (OSCC). Methods : OPN and TIP30 mRNA expressions were examined in OSCC( n = 18 ) and adjacent normal oral mucosa tissue( n = 18 ) by flu- orescence quantitative real-time PCR. The OPN and TIP30 protein expressions were examined in OSCC (n = 70) and normal oral muco- sa samples(n = 20) by En VisionTM. The data were analyzed by SPSS 17.0 software. Results:The expressions of OPN mRNA and pro- tein in OSCC were significantly higher than those in normal tissue(P 〈 0.01 ) ; the expressions of TIP30 mRNA and protein in normal tissue were significantly higher than those in OSCC ( P 〈 0.01 ). OPN and TIP30 mRNA showed negative correlation in the samples. Conclusion:OPN may be invloved in the development of OSCC. The role of TIP30 and OSCC may be contrary.
出处 《实用口腔医学杂志》 CAS CSCD 北大核心 2013年第2期219-223,共5页 Journal of Practical Stomatology
基金 上海市卫生局青年科研项目基金(编号:2009Y060)
关键词 口腔鳞状细胞癌 骨桥蛋白 TIP30基因 实时荧光定量PCR 免疫组织化学 Oral squamous cell carcinoma(OSCC) Osteopontin ( OPN) TIP30 gene Fluorescence quantitativereal- time PCR Immunohistochemistry
  • 相关文献

参考文献12

  • 1Rittling SR, Chambers AF. Role of osteopontin in tumour progression [ J ]. Br J Cancer, 2004, 90 (10) : 1877 - 1881.
  • 2Zhang H, Ye QH, Ren N,et al. The prognostic significance of preoperative plasma levels of osteopontin in patients with hepatocellular carcinoma [ J ]. J Cancer Res Clin Oncol, 2006, 132( 11 ) :709 -717.
  • 3Ogbureke KU, Nikitakis NG, Warburton G, et al. Up-regu- lation of SIBLING proteins and correlation with cognate MMP expression in oral cancer[J]. Oral Oncol, 2007, 43 (9) :920-932.
  • 4Jin H, Valverde P, Chen J. Cloning of hamster osteopontin and expression distribution in normal tissues and experimen- tally induced oral squamouse cell carcinoma[J]. Arch Oral Bid, 2006, 51(3):236-245.
  • 5NicAmhlaoibh R, Shtivelman E. Metastasis suppressor CC3 inhibits angiogenic properties of tumor cells in vitro[ J]. On- eogene, 2001, 20(2):270-275.
  • 6Zhao J, Zhang X, Shi M, et al. TIP30 inhibits growth of HCC cell lines and inhibits HCC xenografts in mice in corn-bination with 5- FU [ J ]. Hepatology, 2006, 44 ( 1 ) : 205 - 215.
  • 7Das R, Mahaheleshwar GH, Kundu GC. Osteopontin in- duces AP. 1- mediated secretion of urokinase-type plasmino- gen activator through c-Sre-dependent epidermal growth fac- tor receptor transactivation in breast cancer ceils[ J]. J Biol Chem, 2004, 279(12) :11051 -11064.
  • 8Song G, Ming Y, Mao Y, et al. Osteopontin prevents curcu- min-induced apoptosis and promotes survival through Akt activation via alpha v beta 3 integrins in human gastric can- cer cells[ J]. Exp Biol Meal (Maywood) , 2008, 233(12) : 1537 - 1545.
  • 9Shang S, Plymoth A, Ge S, et al. Identification of osteopon-tin as a novel marker for early hepatocellular carcinoma[ J]. Hepatology, 2012, 55 (2) :483 - 490.
  • 10Zhao J, Chen J, Lu B, et al. TIP30 induces apoptosis un- der oxidative stress through stabilization of p53 messenger RNA in human hepatocellular carcinoma[ J]. Cancer Res, 2008, 68(11) :4133 -4141.

同被引文献7

  • 1Gimba ER, Tilli TM. Human osteopontin splicing isoforms: Known roles, potential clinical applications and activated signaling pathways[J]. Cancer Lett, 2013, 331 ( 1 ) : 11 - 17.
  • 2Masuzaki R, Karp S J, Omata M. New serum markers of hepatocellular carcinoma [ J ]. Semin Oncol, 2012, 39 (4) : 434 - 439.
  • 3Lim AM, Rischin D, Fisher R, et al. Prognostic signifi- cance of plasma osteopontin in patients with locoregionally advanced head and neck squamous cell carcinoma treated on TROG 02.02 phase III trial[J]. Clin Cancer Res, 2012, 18 (1) :301 -307.
  • 4Rao G, Wang H, Li B, et al. Reciprocal interactions be- tween tumor-associated macrophages and CD44-positive cancer ceils via osteopontin/CD44 promote tumorigenicity in colorectal cancer[ J]. Clin Cancer Res, 2013, 19 (4) :785 - 797.
  • 5Routray S, Kheur SM, Kheur M. Osteopontin : A marker for invasive oral squamous cell carcinoma but not for potentially malignant epithelial dysplasias [ J ]. Ann Diagn Pathol, 2013, 17(5) :421 -424.
  • 6Said HM, Hagemann C, Staab A, et al. Expression patterns of the hypoxia-related genes osteopontin, CA9, erythropoie- tin, VEGF and HIF-lalpha in human glioma in vitro and in vivo[J]. Radiother Oncol, 2007, 83(3) :398 -405.
  • 7施琳,乌新林,赵丽珍,申铁兵.口腔癌中骨桥蛋白及相关因子的表达[J].现代口腔医学杂志,2010,24(4):288-291. 被引量:3

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部